Home » Topics » BioWorld Science

BioWorld Science
RSS

First patients enrolled in phase IIa trial of ORY-2001 in Alzheimer's disease

May 15, 2018

CS-1003 begins phase I trial in advanced solid tumors

May 14, 2018

Polaris collaborates with MD Anderson Cancer Center to utilize immunotherapy platform

May 14, 2018

Poseida Therapeutics presents clinical data on P-BCMA-101 for relapsed/refractory multiple myeloma

May 14, 2018

Beam Therapeutics launches with focus on creating precision genetic medicines through base editing

May 14, 2018

Human evaluation of CAR T cells targeting ROR1 underway

May 14, 2018

Medigene and bluebird bio expand TCR alliance

May 14, 2018

Tumor growth inhibition seen with Jubilant Biosys LSD1/HDAC inhibitors

May 14, 2018

Phase II trial in China studies SHR-1210 for advanced biliary tract cancer

May 14, 2018

Inovio studies VGX-3100 in new phase II trial for HPV-16 or -18 related anal or peri-anal HSIL

May 14, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 30, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...